These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 25387475)

  • 21. Treatment of IgA nephropathy: Recent advances and prospects.
    Coppo R
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S13-S21. PubMed ID: 29606258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gluten sensitivity in patients with IgA nephropathy.
    Smerud HK; Fellström B; Hällgren R; Osagie S; Venge P; Kristjánsson G
    Nephrol Dial Transplant; 2009 Aug; 24(8):2476-81. PubMed ID: 19332868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of IgA nephropathy.
    Feehally J; Allen AC
    Ann Med Interne (Paris); 1999 Feb; 150(2):91-8. PubMed ID: 10392257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advancements in understanding the role of intestinal dysbacteriosis mediated mucosal immunity in IgA nephropathy.
    Fan Y; Wang Y; Xiao H; Sun H
    BMC Nephrol; 2024 Jun; 25(1):203. PubMed ID: 38907188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy.
    Smith AC; Molyneux K; Feehally J; Barratt J
    J Am Soc Nephrol; 2006 Dec; 17(12):3520-8. PubMed ID: 17093066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum anti-dextran antibodies in IgA nephropathy.
    Kennel A; Bene MC; Hurault de Ligny B; Kessler M; Faure G
    Clin Nephrol; 1995 Apr; 43(4):216-20. PubMed ID: 7541737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy.
    Wang J; Anders RA; Wu Q; Peng D; Cho JH; Sun Y; Karaliukas R; Kang HS; Turner JR; Fu YX
    J Clin Invest; 2004 Mar; 113(6):826-35. PubMed ID: 15067315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunoglobulin A (IgA) and its cellular receptors: Recent advances and new pathogenetical hypothesis].
    Amore A; Monteiro R; Coppo R
    G Ital Nefrol; 2006; 23(3):313-22. PubMed ID: 16868911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori participates in the pathogenesis of IgA nephropathy.
    Zhu TT; Wang L; Wang HL; He Y; Ma X; Fan JM
    Ren Fail; 2016 Oct; 38(9):1398-1404. PubMed ID: 27764998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches?
    Floege J
    Am J Kidney Dis; 2011 Dec; 58(6):992-1004. PubMed ID: 21872377
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capsaicin induces high expression of BAFF and aberrantly glycosylated IgA1 of tonsillar mononuclear cells in IgA nephropathy patients.
    Shao J; Peng Y; He L; Liu H; Chen X; Peng X
    Hum Immunol; 2014 Oct; 75(10):1034-9. PubMed ID: 25167771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
    Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
    Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New insights in the pathogenesis of IgA nephropathy.
    Monteiro RC
    Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H
    BMC Nephrol; 2017 Sep; 18(1):301. PubMed ID: 28969604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The possible involvement of intestine-derived IgA1: a case of IgA nephropathy associated with Crohn's disease.
    Terasaka T; Uchida HA; Umebayashi R; Tsukamoto K; Tanaka K; Kitagawa M; Sugiyama H; Tanioka H; Wada J
    BMC Nephrol; 2016 Sep; 17(1):122. PubMed ID: 27596164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of secretory IgA and complement in IgA nephropathy.
    Oortwijn BD; Eijgenraam JW; Rastaldi MP; Roos A; Daha MR; van Kooten C
    Semin Nephrol; 2008 Jan; 28(1):58-65. PubMed ID: 18222347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transferrin receptor engagement by polymeric IgA1 induces receptor expression and mesangial cell proliferation: role in IgA nephropathy.
    Tamouza H; Vende F; Tiwari M; Arcos-Fajardo M; Vrtovsnik F; Benhamou M; Monteiro RC; Moura IC
    Contrib Nephrol; 2007; 157():144-7. PubMed ID: 17495453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
    Novak J; Tomana M; Matousovic K; Brown R; Hall S; Novak L; Julian BA; Wyatt RJ; Mestecky J
    Kidney Int; 2005 Feb; 67(2):504-13. PubMed ID: 15673298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of IgA Class Switch Recombination in Immunoglobulin A Nephropathy: Retinoic Acid Signaling and BATF.
    He L; Peng X; Chen Y; Liu G; Liu Z; Zhu J; Liu Y; Liu H; Liang Y; Liu F; Sun L; Peng Y
    Am J Nephrol; 2016; 43(3):179-94. PubMed ID: 27073891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of tonsillectomy in IgA nephropathy.
    Feriozzi S; Polci R
    J Nephrol; 2016 Feb; 29(1):13-9. PubMed ID: 26582216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.